EP Patent

EP1474198A1 — Systems and methods for clearing aerosols from the effective anatomic dead space

Assigned to Novartis AG · Expires 2004-11-10 · 22y expired

What this patent protects

An aerosolization device (10) having a housing (26) with a mouthpiece (14), an aerosol generator (16), a flow sensor (32) and a controller (28). The controller (28) is configured to begin operation of the aerosol generator (16) upon receipt of a signal from the flow sensor (32) i…

USPTO Abstract

An aerosolization device (10) having a housing (26) with a mouthpiece (14), an aerosol generator (16), a flow sensor (32) and a controller (28). The controller (28) is configured to begin operation of the aerosol generator (16) upon receipt of a signal from the flow sensor (32) indicating that a threshold flow rate is achieved by a user when inhaling a tidal breath through the mouthpiece (14), and to stop operation after the passage of an operation time period that is selected such that continuation of the tidal breath delivers substantially all of the aerosol to the lungs.

Drugs covered by this patent

Patent Metadata

Patent number
EP1474198A1
Jurisdiction
EP
Classification
—
Expires
2004-11-10
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.